Skip to content

Response of Bhrajaka Pitha to Ayurvedic management in Radiation-Induced Skin Reactions of cancer patients

Evaluation of Bhrajaka Pitha with external application of Satadhouta Ghritha as add-on therapy in comparison with internal Ayurvedic medications in cancer patients with radiation-induced skin reactions. - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/02/080127
Enrollment
24
Registered
2025-02-07
Start date
Unknown
Completion date
Unknown
Last updated
2026-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C50-C50- Malignant neoplasms of breast Health Condition 2: C14- Malignant neoplasm of other and ill-defined sites in the lip, oral cavity and pharynx

Interventions

None listed

Sponsors

Sruthi K P
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1 Diagnosed case of cancer of stage 1, 2, or 3 of Breast and Head and neck who had completed the course of radiation therapy and complaints about radiation-induced hyperpigmentation. 2 Participants between the age group of 30-65 years, irrespective of sex

Exclusion criteria

Exclusion criteria: 1. Participants with pre-existing skin rash, ulceration, or open wound in the treatment area 2. Participants with any known allergic reaction toward the medicine.

Design outcomes

Primary

MeasureTime frame
Bhrajaka Pitha checklist score. Timepoint: 18 MONTHS

Secondary

MeasureTime frame
RTOG ScoreTimepoint: 18 Moths;VAS ScoreTimepoint: 18 Months ;TemperatureTimepoint: 18 Months;Felix Von Luschan Skin Color ChartTimepoint: 18 Months

Countries

India

Contacts

Public ContactSruthi K P

KUHS

drpradeep601@gmail.com986606351

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 29, 2026